| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 1 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Proteasome Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Thalidomide Analog [EPC] | 9 | 0.0000 |
| 10 | Corticosteroid [EPC] | 16 | 0.0000 |
| 11 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 12 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 13 | Tumor Necrosis Factor Blocker [EPC] | 6 | 0.0000 |
| 14 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 | 0.0000 |
| 15 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 16 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 17 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |